ArticleBMC public health2025
Cost-effectiveness of eHealth-based HIV pre-exposure intervention for recreational drugs using among men who have sex with men in China: a modelling study.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Cost-effectiveness of concurrently available oral and long-acting injectable pre-exposure prophylaxis for preventing HIV infections among men who have sex with men in eastern China: A modelling study.BMC public health · 2026Article
- Advancing Precision Public Health: an implementation science framework for HIV Cluster Detection and Response driven by molecular epidemiology.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundRecreational drug (RD) is widespread among men who have sex with men (MSM), inspiring "Chemsex" which then exacerbates the spread of HIV. Electronic health (eHealth) can effectively intervene in RD use, while the efficacy of oral pre-exposure prophylaxis (PrEP) in HIV prevention has been well-documented. However, eHealth and PrEP have not been implemented on a large-scale in China, and the cost-effectiveness of intervention remains uncertain. This study conducted a dynamic modelling to predict HIV prevalence trends among MSM and the cost-effectiveness of various interventions.
methodsThrough constructing the HIV-RD model, HIV trends among MSM for the next 30 years are projected. Social network intervention and customized short message service (SMS) in eHealth were combined with PrEP to form 9 intervention scenarios: status quo; social network intervention; SMS; 30%PrEP; 70%PrEP; social network intervention with 30%PrEP; social network intervention with 70%PrEP; SMS with 30%PrEP; SMS with 70%PrEP. The cost-effectiveness of each scenario was evaluated economically, and the results were presented as incremental cost-effectiveness ratio (ICER).
findingsImplementing interventions would prevent 57,937-142,892 HIV infections and 24,091-61,680 deaths. From societal perspective, all interventions' ICERs were from $11,669 to $29,806. Social network intervention was advantageous, saving about $1.97 billion while gaining 169,354 quality-adjusted life years (QALYs). SMS, social network intervention with 30% PrEP were highly cost-effective, with ICERs of $5,869 and $20,325. Sensitivity analysis found that PrEP's costs had the most significant impact.
conclusionsIn China, implementing eHealth, expanding PrEP, and joint interventions for MSM are cost-effective. Considering funding, social network intervention could be prioritized.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.